Tuberculosis Diagnostics Market Driving Growth in United States | Exhibit 4.9% CAGR by 2028

 

The global tuberculosis diagnostics market size was valued at USD 1.96 billion in 2020. The market valuation is predicted to increase from USD 2.05 billion in 2021 to USD 2.87 billion in 2028 at a CAGR of 4.9% during the projected timeline. The market is driven by the need for improved diagnostics solutions in order to address the increasing burden of tuberculosis. Continuous advances in TB diagnostics will transform the market outlook in the forthcoming years, states Fortune Business Insights in its report titled Tuberculosis (TB) Diagnostics Market, 2021-2028."        

Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/tuberculosis-tb-diagnostics-market-102009          

Tuberculosis (TB) is a highly contagious pulmonary disorder caused by Mycobacterium tuberculosis – a type of bacteria that typically attacks the patient’s lungs. The infection can also other body parts such as the brain and spine. TB blood test and TB skin test are commonly used methods for the detection of this bacteria in the body. A significant occurrence of the disease worldwide has created the need for improved diagnostic technologies. Active healthcare investments to address the rising burden of the disease will fuel the market size during 2021-2028.   

Regional Insights:       

North America generated USD 0.56 billion in the worldwide tuberculosis (TB) diagnostics market share in 2020 and will grow substantially through 2028. The regional growth is attributable to the economically stable and highly aware population. An established healthcare system and widespread adoption of technologically advanced products will benefit the regional outlook.

Europe is slated to witness notable growth in the market led by rising R&D in the field of tuberculosis diagnostics. Meanwhile, the market in Asia Pacific will gain traction led by the widespread occurrence of TB and a vast geriatric population base.

The Report Lists the Key Players Profiled in the Market Report:        

·         F. Hoffmann-La Roche Ltd (Basel, Switzerland)

·         bioMérieux SA (Marcy l'Etoile, France)

·         QIAGEN (Venlo, Netherlands)

·         BD (Becton, Dickinson and Company) (New Jersey, U.S.)

·         Danaher (Washington D.C., U.S.)

·         Thermo Fisher Scientific Inc. (Waltham, U.S.)

·         Abbott (Illinois, U.S.)

·         Hologic Inc. (Marlborough, U.S.)

·         Hain Lifescience GmbH (Nehren, Germany)

·         Oxford Immunotec (Abingdon, U.K.)

 

About Us:  

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data. 

At Fortune Business Insights™, we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges. 

 

Comments

Popular posts from this blog

U.S. Acne Treatment Market 2023 Growth, Trends, Demand and Business Opportunities -2029

Remote Patient Monitoring Devices Market Recent Development, Share, Size, Segments and Revenue Forecast

 Dental Prosthetics Market Size, Segmentation, Growth Factor,  Demands, Analysis, Regional Forecast to 2028